HuGE Literature Finder
Records 1-23
|
Association between SLCO1A2 genetic variation and methotrexate toxicity in human rheumatoid arthritis treatment.
Journal of biochemical and molecular toxicology 2020 Apr e22513. Wang Jiayi, Yin Jun, Li Wei, Xiao Chunyuan, Han Jie, Zhou Fanf |
|
Effects of Trough Concentration and Solute Carrier Polymorphisms on Imatinib Efficacy in Chinese Patients with Chronic Myeloid Leukemia.
Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 2020 23 (1): 1-9. Wang Qing, Jiang Zhi-Ping, Zeng Jing, Zhu Yan, Cai Hua-Lin, Xiang Da-Xiong, He Qun, Shi Xiao-Liu, Zhong An-Ni, Zhao Xie-Lan, Xu Pi |
|
Genetic associations of docetaxel-based chemotherapy-induced myelosuppression in Chinese Han population.
Journal of clinical pharmacy and therapeutics 2019 Nov . Ren Weihua, Zhou Chenxi, Liu Yedong, Su Keli, Jia Li, Chen Luan, Li Mo, Ma Jingsong, Zhou Wei, Zhang Suli, Zhang Di, Cong Zhiliang, Niu Xuecai, Zhang Shengui, Shen Lu, Huai Cong, Sun Xiaofang, Li Guorong, Qin Shengying, Guo Lia |
Joint genome-wide association study of progressive supranuclear palsy identifies novel susceptibility loci and genetic correlation to neurodegenerative diseases.
Molecular neurodegeneration 2018 Aug 13 (1): 41. Chen Jason A, Chen Zhongbo, Won Hyejung, Huang Alden Y, Lowe Jennifer K, Wojta Kevin, Yokoyama Jennifer S, Bensimon Gilbert, Leigh P Nigel, Payan Christine, Shatunov Aleksey, Jones Ashley R, Lewis Cathryn M, Deloukas Panagiotis, Amouyel Philippe, Tzourio Christophe, Dartigues Jean-Francois, Ludolph Albert, Boxer Adam L, Bronstein Jeff M, Al-Chalabi Ammar, Geschwind Daniel H, Coppola Giovan |
|
Replication of progressive supranuclear palsy genome-wide association study identifies SLCO1A2 and DUSP10 as new susceptibility loci.
Molecular neurodegeneration 2018 Jul 13 (1): 37. Sanchez-Contreras Monica Y, Kouri Naomi, Cook Casey N, Serie Daniel J, Heckman Michael G, Finch NiCole A, Caselli Richard J, Uitti Ryan J, Wszolek Zbigniew K, Graff-Radford Neill, Petrucelli Leonard, Wang Li-San, Schellenberg Gerard D, Dickson Dennis W, Rademakers Rosa, Ross Owen |
|
Effect of ABCC2 and ABCG2 Gene Polymorphisms and CSF-to-Serum Albumin Ratio on Ceftriaxone Plasma and Cerebrospinal Fluid Concentrations.
Journal of clinical pharmacology 2018 Jun . Allegra Sarah, Cardellino Chiara Simona, Fatiguso Giovanna, Cusato Jessica, De Nicolò Amedeo, Avataneo Valeria, Bonora Stefano, D'Avolio Antonio, Di Perri Giovanni, Calcagno Andr |
|
Association between a microRNA binding site polymorphism in SLCO1A2 and the risk of delayed methotrexate elimination in Chinese children with acute lymphoblastic leukemia.
Leukemia research 2018 02 65 61-66. Wang Shu-Mei, Zeng Wei-Xin, Wu Wan-Shui, Sun Lu-Lu, Yan D |
|
SLCO1A2, SLCO1B1 and SLCO2B1 polymorphisms influences chloroquine and primaquine treatment in Plasmodium vivax malaria.
Pharmacogenomics 2017 Oct . Sortica Vinicius A, Lindenau Juliana D, Cunha Maristela G, O Ohnishi Maria Deise, R Ventura Ana Maria, Ribeiro-Dos-Santos Ândrea Kc, Santos Sidney Eb, Guimarães Luciano Sp, Hutz Mara |
|
The SLCO1A2 -189_-188InsA polymorphism reduces clearance of rocuronium in patients submitted to elective surgeries.
European journal of clinical pharmacology 2017 Apr . Costa A C C, Coelho E B, Lanchote V L, Correia B V, Abumansur J T, Lauretti G R, de Moraes N |
|
MiR-pharmacogenetics of methotrexate in childhood B-cell acute lymphoblastic leukemia.
Pharmacogenetics and genomics 2016 Sep . Iparraguirre Leire, Gutierrez-Camino Angela, Umerez Maitane, Martin-Guerrero Idoia, Astigarraga Itziar, Navajas Aurora, Sastre Ana, Garcia de Andoin Nagore, Garcia-Orad Afri |
|
High-throughput pharmacogenetics identifies SLCO1A2 polymorphisms as candidates to elucidate the risk of febrile neutropenia in the breast cancer RAPP-01 trial.
Breast cancer research and treatment 2015 Sep 153 (2): 383-9. Callens Céline, Debled Marc, Delord Marc, Turbiez-Stalain Isabelle, Veyret Corinne, Bièche Ivan, Brain Etien |
|
Genetic link with cholelithiasis among pediatric SCA Tunisian patients: Examples of UGT1A1, SLCO1A2 and SLCO1B1.
Hematology (Amsterdam, Netherlands) 2015 Jul . Chaouch Leila, Kalai1 Miniar, Darragi Imen, Boudrigua Imen, Chaouachi Dorra, Ammar Slim Ben, Mellouli F, Bjaoui M, Abbes Sal |
|
Relationship between SLCO1B3 and ABCA3 polymorphisms and imatinib response in chronic myeloid leukemia patients.
Hematology (Amsterdam, Netherlands) 2015 Apr 20 (3): 137-42. de Lima Luciene Terezina, Bueno Carolina Tosin, Vivona Douglas, Hirata Rosario Domiguez Crespo, Hirata Mario Hiroyuki, Hungria Vania Tiestsche de Moraes, Chiattone Carlos Sérgio, Zanichelli Maria Aparecida, Chauffaille Maria de Lourdes Lopes Ferrari, Guerra-Shinohara Elvira Mar |
|
Genotype and allele frequencies of drug-metabolizing enzymes and drug transporter genes affecting immunosuppressants in the Spanish white population.
Therapeutic drug monitoring 2014 Apr 36 (2): 159-68. Bosó Virginia, Herrero María J, Buso Enrique, Galán Juan, Almenar Luis, Sánchez-Lázaro Ignacio, Sánchez-Plumed Jaime, Bea Sergio, Prieto Martín, García María, Pastor Amparo, Sole Amparo, Poveda José Luis, Aliño Salvador |
|
Reduced ABCG2 and increased SLC22A1 mRNA expression are associated with imatinib response in chronic myeloid leukemia.
Medical oncology (Northwood, London, England) 2014 Mar 31 (3): 851. de Lima Luciene Terezina, Vivona Douglas, Bueno Carolina Tosin, Hirata Rosario D C, Hirata Mario H, Luchessi André D, de Castro Fabíola Attié, de Lourdes F Chauffaille Maria, Zanichelli Maria A, Chiattone Carlos S, Hungria Vania T M, Guerra-Shinohara Elvira |
|
Simultaneous Pharmacogenetics-Based Population Pharmacokinetic Analysis of Darunavir and Ritonavir in HIV-Infected Patients.
Clinical pharmacokinetics 2013 Mar . Moltó J, Xinarianos G, Miranda C, Pushpakom S, Cedeño S, Clotet B, Owen A, Valle M |
|
Polymorphisms in the methotrexate transport pathway: a new tool for MTX plasma level prediction in pediatric acute lymphoblastic leukemia.
Pharmacogenetics and genomics 2013 Feb 23 (2): 53-61. Lopez-Lopez Elixabet, Ballesteros Javier, Piñan Maria A, Sanchez de Toledo José, Garcia de Andoin Nagore, Garcia-Miguel Purificacion, Navajas Aurora, Garcia-Orad Afri |
|
Determinants of darunavir cerebrospinal fluid concentrations: impact of once-daily dosing and pharmacogenetics.
AIDS (London, England) 2012 Jul 26 (12): 1529-33. Calcagno Andrea, Yilmaz Aylin, Cusato Jessica, Simiele Marco, Bertucci Roberto, Siccardi Marco, Marinaro Letizia, D'Avolio Antonio, Di Perri Giovanni, Bonora Stefa |
|
Pharmacokinetic impact of SLCO1A2 polymorphisms on imatinib disposition in patients with chronic myeloid leukemia.
Clinical pharmacology and therapeutics 2011 Jul 90 (1): 157-63. Yamakawa Y, Hamada A, Shuto T, Yuki M, Uchida T, Kai H, Kawaguchi T, Saito |
|
Frequencies of single-nucleotide polymorphisms of SLCO1A2, SLCO1B3 and SLCO2B1 genes in a Finnish population.
Basic & clinical pharmacology & toxicology 2011 Jan 108 (1): 9-13. Laitinen Alli, Niemi Mik |
|
Polymorphisms of the nuclear receptor pregnane X receptor and organic anion transporter polypeptides 1A2, 1B1, 1B3, and 2B1 are not associated with breast cancer risk.
Breast cancer research and treatment 2011 Jan 125 (2): 563-9. Justenhoven Christina, Schaeffeler Elke, Winter Stefan, Baisch Christian, Hamann Ute, Harth Volker, Rabstein Sylvia, Spickenheuer Anne, Pesch Beate, Brüning Thomas, Ko Yon-Dschun, Schwab Matthias, Brauch Hiltr |
|
Loci from a genome-wide analysis of bilirubin levels are associated with gallstone risk and composition.
Gastroenterology 2010 Dec 139 (6): 1942-1951.e2. Buch Stephan, Schafmayer Clemens, Völzke Henry, Seeger Marcus, Miquel Juan F, Sookoian Silvia C, Egberts Jan H, Arlt Alexander, Pirola Carlos J, Lerch Markus M, John Ulrich, Franke Andre, von Kampen Oliver, Brosch Mario, Nothnagel Michael, Kratzer Wolfgang, Boehm Bernhard O, Bröring Dieter C, Schreiber Stefan, Krawczak Michael, Hampe Joch |
|
Polymorphisms in human organic anion-transporting polypeptide 1A2 (OATP1A2): implications for altered drug disposition and central nervous system drug entry.
The Journal of biological chemistry 2005 Mar 280 (10): 9610-7. Lee Wooin, Glaeser Hartmut, Smith L Harris, Roberts Richard L, Moeckel Gilbert W, Gervasini Guillermo, Leake Brenda F, Kim Richard |
- Page last reviewed:Oct 1, 2020
- Page last updated:Apr 15, 2021
- Content source: